Loading
Sentiment · FY2026 Q4
On July 29, 2026, Procter & Gamble announced that Shailesh Jejurikar, President and Chief Executive Officer, was appointed Chairman of the Board effective August 1, 2026, holding the role in addition to his existing position. Executive Chairman Jon Moeller will retire from the board effective July 31, 2026, and from the company effective August 14, 2026, after 38 years of service that included the Executive Chairman, CEO, COO, and CFO roles.
Procter & Gamble delivered Q3 FY26 with organic sales increasing more than 3% and core EPS of $1.59, up 3% on a currency-neutral basis. Broad-based organic sales acceleration reflected innovation-driven volume recovery. China grew in a challenging market. Middle East conflict costs created headwinds, compressing core gross margin by 100 basis points and operating margin by 80 basis points. FY2026 guidance was maintained at in-line to +4% for organic sales and core EPS, with management expecting the lower end due to geopolitical costs.
Demand | Competitive Dynamics | Pricing | Innovation & R&D | Geographic Expansion | Cost Pressure | Guidance Reliability | Trade Tariffs | |
|---|---|---|---|---|---|---|---|---|
| 2025Q2 | 7 | 2 | 4 | 4 | 3 | 1 | 2 | |
| 2025Q3 | 7 | 3 | 2 | 2 | 3 | 2 | 3 | 4 |
| 2025Q4 | 4 | 2 | 4 | 3 | 2 | 2 | 2 | 2 |
| 2026Q1 | 4 | 4 | 3 | 3 | 6 | 2 | 2 | |
| 2026Q2 | 6 | 4 | 3 | 4 | 1 | 3 | 1 | |
| 2026Q3 | 6 | 7 | 5 | 2 | 2 | 7 | 2 | 1 |
| '25Q2 | '25Q3 | '25Q4 | '26Q1 | '26Q2 | '26Q3 | |
|---|---|---|---|---|---|---|
| Demand | 7 | 7 | 4 | 4 | 6 | 6 |
| Competitive Dynamics | 2 | 3 | 2 | 4 | 4 | 7 |
| Pricing | 4 | 2 | 4 | 3 | 3 | 5 |
| Innovation & R&D | 4 | 2 | 3 | 3 | 4 | 2 |
| Geographic Expansion | 3 | 3 | 2 | 6 | 1 | 2 |
| Cost Pressure | 1 | 2 | 2 | 2 | 3 | 7 |
| Guidance Reliability | 2 | 3 | 2 | 1 | 2 | |
| Trade Tariffs | 4 | 2 | 2 | 1 |
| Analyst | Firm | Questions (Challenge)Percentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| Rob Ottenstein | Evercore ISI | 8 (13%) |
| Chris Carey | Wells Fargo | 8 (13%) |
| Olivia Tong | Raymond James |
| Steve Powers | Deutsche Bank | 8 (13%) |
| Dara Mohsenian | Morgan Stanley | 8 (0%) |
| Rob Moskow | TD Cowen | 8 (25%) |
| Kaumil Gajrawala | Jefferies | 8 (0%) |
| Lauren Lieberman | Barclays | 7 (29%) |
| Filippo Falorni | Citigroup | 7 (14%) |
| Andrea Teixeira | JPMorgan | 7 (0%) |
| Firm | Analysts | Questions (Challenge)Percentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| Raymond James | 1 | 8 (0%) |
| Wells Fargo | 1 | 8 (13%) |
| Morgan Stanley | 1 | 8 (0%) |
| Deutsche Bank | 1 | 8 (13%) |
| Evercore ISI | 1 | 8 (13%) |
| TD Cowen | 1 | 8 (25%) |
| Jefferies | 1 | 8 (0%) |
| Bank of America | 2 | 7 (0%) |
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|
| FY2025 Q1 | $21.74B | -0.6% | $1.61 | -12.0% | 26.7% | 18.2% | $3.31B |
| FY2025 Q2 | $21.88B | +2.1% | $1.88 | +34.3% | 26.2% | 21.2% | $3.90B |
| FY2025 Q3 | $19.78B | -2.1% | $1.54 | +1.3% | 23.0% | 19.1% | $2.85B |
| FY2025 Q4 | $20.89B | +1.7% | $1.48 | +16.5% | 20.8% | 17.3% | $3.99B |
| FY2026 Q1 | $22.39B | +3.0% | $1.95 | +21.1% | 26.2% | 21.2% | $4.21B |
| FY2026 Q2 | $22.21B | +1.5% | $1.78 | -5.3% | 24.2% | 19.5% | $3.81B |
| FY2026 Q3 | $21.23B | +7.4% | $1.63 | +5.8% | 21.5% | 18.7% | $3.03B |
| FY2026 Q4 | $21.20B | +1.5% | $1.26 | -14.9% | 18.6% | 14.1% | $4.87B |
Management’s own words, often on a non-GAAP, constant-currency, or adjusted basis — so these can differ from the GAAP figures above (e.g. constant-currency revenue growth excludes currency swings).
| Company | Score | Trend | Rev YoY |
|---|---|---|---|
PG The Procter & Gamble Company | 5 | +7.4% | |
| CHD Church & Dwight | 6 | +0.1% | |
| CL Colgate-Palmolive | 7 | +8.4% | |
| CLX Clorox | 4 | +0.1% | |
| EL Estée Lauder Companies (The) | 9 | +4.6% | |
| KMB Kimberly-Clark | 5 | -14.0% | |
| KVUE Kenvue | 7 | +4.5% |